4

Making the difference

Helping women, children and their families
make informed and powerful decisions about
their health

3

Global collaboration

Bringing together experts from all over the world
to improve maternal and child health

2

Understanding the Immune Response

Harnessing the body’s response to HIV and antiretrovirals
to improve treatment and quality of life

1

The right drug, the right dose

Generating scientific information necessary to market drugs
at doses that are safe and effective for children

virus_slider

Fighting Antimicrobial Resistance

Ensuring effective treatments are available for common infections
for generations to come

6

Working smarter, not harder

Standardizing best practices across disease areas
and populations to improve paediatric infectious disease research

5

SCIENTIFIC RESEARCH

Paving the way to better healthcare
and better lives.

LATEST NEWS

florian-wehde-1092251-unsplash-min

2nd EPIICAL General Assembly meeting, 14-16 November 2018, Madrid

13 November, 2018 - 10:47:41

Madrid will play host to the 2nd EPIICAL General Assembly meeting from November 14th to 16th 2018. We look forward to welcoming our project partners from 26 organisations across 4 different continents for a stimulating and engaging 3 days together. ViiV Healthcare, who finances the milestone project, will also be represented.READ MORE

agustin-diaz-185846-unsplash-1024x683

ZIKAction Consortium meeting in Rio de Janeiro, 3-5 November, 2018

29 October, 2018 - 12:10:14

On November 3rd-5th the annual ZIKAction Consortium meeting will be held in Rio de Janeiro, Brazil. Around 40 researchers, health professionals and project managers from partner organizations are planning to participate in the meeting which aims at overviewing the ongoing project studies and setting goals for the upcoming year.READ MORE

CHAPAS team win EDCTP Outstanding Research Team Prize

19 October, 2018 - 5:14:15

Congratulations to the CHAPAS paediatric HIV trials team! It has been awarded the prestigious European and Developing Countries Clinical Trials Partnership (EDCTP) prize for Outstanding Research Team. The EDCTP prize recognises the team’s scientific excellence, and their major contribution to strengthening clinical research capacity in Africa, and networking between the partners. The CHAPAS (Children with…READ MORE

THE PENTA ID NETWORK

The PENTA-ID Network brings together key stakeholders in paediatric infectious disease, including researchers, clinicians, regulatory bodies, the pharmaceutical industry and patients and their families, to plan and carry out high quality clinical research and training. The network began in 1991 as PENTA, the Paediatric European Network for Treatment of AIDS, and focused on conducting clinical trials on antiretroviral therapy among HIV-infected children. It later integrated with the European Collaborative Study, one of the largest cohorts of children born to HIV-positive mothers.

In 2011 the network officially became PENTA-ID (Infectious Diseases), expanding and applying its expertise in HIV to other paediatric infectious diseases. The network now spans over 90 clinical sites in 18 countries, providing the access to paediatric patients necessary to perform clinical research, and leverages the expertise and experience in paediatric infectious disease of hundreds of participating researchers and physicians. In addition to coordinating and participating in trials and cohort studies, the network develops treatment guidelines and training programmes for health care professionals on various aspects of prevention and treatment of paediatric infectious disease, and contributes to European and global efforts to improve research infrastructure and harmonize and streamline research methods.

ALWAYS EXPANDING

The PENTA-ID network continues to grow, bringing together patients and their care-givers worldwide to address a wide range of healthcare issues.

90

CLINICAL SITES

18

COUNTRIES

27

YEARS OF ACTIVITY

22

CURRENT PROJECTS